14 March 2019
Sofitel Legend Amsterdam The Grand
If you are interested in sponsoring the 2018 BioCapital Europe Conference please contact email@example.com or call +44 020 7250 7050
Event Organised by
LSP (Life Sciences Partners)
LSP (Life Sciences Partners) is a leading independent European investment firm, providing financing for private and public life-science companies. Since the late 1980s, LSP’s management has invested in a large number of highly innovative enterprises, many of which have grown to become leaders of the global life-science industry. With over EUR 1 billion of investment capital raised to date and offices in Amsterdam, Munich and Boston, LSP is one of Europe’s largest and most experienced specialist life-science investors.
For more information, please visit lspvc.com.
Gold Sponsors 2018
LifeSci Advisors, LLC (www.lifesciadvisors.com) is a unique investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. With a local presence in New York, Boston, Chicago, Philadelphia, London, Geneva and Tel Aviv, the firm provides the highest quality service for its clients through its deep sector specialization. Our roster of PhDs enables us to better understand our clients’ R&D, regulatory, and commercial strategy, and our team of capital markets, investor relations, and public relations specialists help our clients effectively communicate to the marketplace. This combination of life sciences, capital markets, and investor relations competencies allows us to provide a valuable and highly differentiated service offering to our clients.
Euronext is the leading pan-European exchange in the Euro zone with more than 1 300 listed issuers worth close to €3.1 trillion in market capitalization as of end October 2016, an unmatched blue chip franchise consisting of 25 issuers in the EURO STOXX 50® benchmark and a strong diverse domestic and international client base.
Euronext operates regulated and transparent equity and derivatives markets. Its total product offering includes Equities, Exchange Traded Funds, Warrants & Certificates, Bonds, Derivatives, Commodities and Indices. Euronext also leverages its expertise in running markets by providing technology and managed services to third parties. Euronext operates regulated markets, Alternext and the Free Market; in addition it offers EnterNext, which facilitates SMEs’ access to capital markets.
Russell Reynolds Associates
Lunch Sponsor 2018
Coulter Partners is a board and senior level global executive search specialist focused exclusively on Life Sciences. We work closely with those at the cutting edge of innovation in the industry in order to understand their challenges. With an extensive global network and expertise gained over 25 years in the sector, we have become trusted advisers on leadership in the pharmaceuticals, biotechnology, medical devices, diagnostics, CRO and services sectors. We also work with the global investor community, hiring for their own teams as well as building the boards and executive leadership teams of their portfolios companies. The largest dedicated Life Science search boutique in North America and Europe, we work in a unique way. We share knowledge and connections across the globe, as one team with one goal. To bring clients the world’s best talent.
Tea & Coffee Breaks Sponsor 2016
EY is a global leader in assurance, tax, transaction and advisory services. The insights and quality services we deliver help build trust and confidence in the capital markets and in economies the world over. We develop outstanding leaders who team to deliver on our promises to all of our stakeholders. In so doing, we play a critical role in building a better working world for our people, for our clients and for our communities.
How EY’s Global Life Sciences Sector can help your business
Life sciences companies — from emerging start-ups to multinational enterprises — face new challenges in a rapidly changing health care ecosystem. Payers and regulators are increasing scrutiny and accelerating the transition to value and outcomes. Big data and patient-empowering technologies are driving new approaches and enabling transparency and consumerism. Players from other sectors are entering health care, making collaborations increasingly complex. These trends challenge every aspect of the life sciences business model, from R&D to marketing.
Our Global Life Sciences Sector brings together a worldwide network — more than 7,000 sector-focused assurance, tax, transaction and advisory professionals — to anticipate trends, identify their implications and develop points of view on responding to critical issues. We can help you navigate your way forward and achieve success in the new ecosystem.
Drinks Reception Sponsor 2017
Loyens & Loeff
Loyens & Loeff offers top-level legal and tax advice for international businesses, financial institutions and government bodies.
Our Investment Management practice is the largest to offer a full range of investment management services in the Benelux. Our practice is multidisciplinary and closely integrated with other related practice areas, such as Private Equity (focusing specifically on private equity transactions such as leveraged buyouts and venture capital transactions), Tax, Real Estate and Banking & Finance. Our Investment Management practice also works closely with our firm’s Pharmaceuticals & Life Sciences Team and Healthcare Team, offering our clients in-depth sector knowledge, which enables us to offer truly integrated services.
Thanks to our closely collaborating legal and tax practices and our extensive sector knowledge, we have built up a unique and very solid position in the market, which enables us to effectively structuring and supervising both domestic and international matters.
Contributing Sponsors 2018
Allen & Overy
Allen & Overy Amsterdam is known for its individual experts and their ability to join forces, across practice areas and borders, to get deals done and to find solutions in highly complex cases. We are universally recognised market leaders in corporate transactions, banking & capital markets, governance & regulatory and disputes. Our global span of 44 offices with over 5,400 people and 554 partners covers established and emerging economies in the West and East and contains a network of over 90 highly experienced lawyers in life sciences.
We offer full-service and dedicated support for companies in the life sciences sector covering investments, start-ups and (venture) financing, mergers & acquisitions, IPO’s, capital market transactions, funds, intellectual property (contentious and non-contentious), regulatory and dispute resolution. Our experts have in-depth knowledge, presence and focus in the Dutch market and work together cross practice on a day-to-day basis. We cover all relevant areas, including pharma, biotech, medical devices, connected health, and consumer healthcare. Our unique experience of working with all relevant parties in the sector, from leading pharmaceutical, generics, biotech and medtech companies, as well as investors, universities and financial institutions has enhanced our ability to identify and anticipate the latest trends in the life sciences sector. Legal and regulatory developments in the Life Sciences sector are the topic of our dedicated blog, the Life Sciences Hub, and our CRISPR microsite, focusing on CRISPR related topics.
Dechert is a leading global law firm focused on sectors with the greatest complexities and highest regulatory demands. We deliver practical commercial insight and judgment to our clients’ most important matters. Leaders in the industry rely on Dechert’s top-ranked life sciences practice to understand the business opportunities and challenges they face and deliver practical commercial insight and judgment. We offer a complete range of transactional, regulatory and dispute resolution services to life sciences companies around the world and at all stages of growth. Whether guiding a start-up biotech firm through its first round of funding, licensing a medical device company’s patents or winning antitrust, securities or patent disputes, we approach each matter with the resources of a major international firm and the focus and depth of a boutique.
Eversheds Sutherland (Netherlands) B.V. is an established practice of lawyers and civil law notaries with offices in Amsterdam and Rotterdam. We are a full service business law firm with specialist expertise in areas including corporate law and M&A, commercial agreements, employment and labour law, banking and finance, real estate, antitrust & EU law, disputes and litigation, information technology and intellectual property. We are part of Eversheds Sutherland International, one of the world’s leading international law firms. The Life Sciences Group of Eversheds Sutherland is a highly recommended, multi-disciplinary legal team with extensive experience of the issues faced by the different sectors of the pharmaceutical, biosciences and medical devices industries. Specialists across the Group have extensive experience of the issues faced by the international biomedical industry with patent specialists across the world providing cutting-edge advice to the life sciences sector. Our Life Sciences Group is highly integrated and are able to advise you in multiple jurisdictions.
Kempen Corporate Finance
Kempen Corporate Finance is uniquely positioned as a dedicated specialist adviser in the life sciences & healthcare sector. Over the past years, we have built a strong position and extensive track-record in European IPOs and other capital market transactions and have emerged as a trusted adviser in various cross-border mergers & acquisitions and other advisory services. We combine our in depth knowledge of the financial sector with a scientific background and extensive business experience.
Innovations, designs and trademarks are a valuable asset in any business. They enhance a company’s distinguishing capacity, strengthen its competitive position and make it more attractive to investors. Therefore, there is every reason to give Intellectual Property (IP) a prominent place in your business strategy. With over 70 European patent and trademark attorneys, NLO is one of the largest IP consultancies in Europe with offices in the Netherlands and Belgium. We support our clients by fortifying their innovations. With about 20 (European) patent attorneys specialised in Biotechnology and Life Sciences, NLO has experienced dedicated teams. Our client list includes multinationals, SMEs, universities, R&D and governmental organizations.
Odgers Berndtson is one of the most prominent executive search firms in the world with 58 offices in 29 countries. We are one of the biggest in Europe and worldwide number 6.
We provide organisations with the tools to identify, attract and develop extraordinary executives. We work with organisations of every size, from the smallest start-ups, to emerging regional players, to the very best known players in the largest therapy areas.
We strongly believe we understand the dynamics of the Life sciences industry, and what it takes to succeed at every stage of a company’s growth.
At Spencer Stuart, we know how much leadership matters. We are trusted by organizations around the world to help them make the senior-level leadership decisions that have a lasting impact on their enterprises.
Privately held since 1956, we focus on delivering knowledge, insight and results though the collaborative efforts of a team of experts across 56 offices and 30 countries. We help clients address their evolving leadership needs in areas such as senior-level executive search, board recruitment, board effectiveness, succession planning, in-depth senior management assessment and many other facets of organizational effectiveness.
For more information, please visit www.spencerstuart.com or contact JP Heldt, European MedTech Practice, Healthcare, Amsterdam JPHeldt@SpencerStuart.com or Julie Rahman, European Healthcare and Private Equity Practices, LondonJRahman@SpencerStuart.com